AEON Biopharma, Inc. (AEON) — Cash Flow Quality Index
AEON Biopharma, Inc. (AEON) has a Cash Flow Quality Index of -0.87x as of March 2025. Operating cash flow of $-7.91 Million is below net income of $9.10 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore AEON Biopharma, Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
AEON Biopharma, Inc. Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for AEON Biopharma, Inc. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see AEON Biopharma, Inc. cash flow conversion.
Annual Cash Flow Quality Index for AEON Biopharma, Inc. (2019–2024)
Year-by-year earnings quality comparison for AEON Biopharma, Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.48x | $-20.29 Million | $42.01 Million | ▼ -73.2% |
| 2019 | -0.28x | $-44.73 Million | $160.31 Million | — |